Literature DB >> 16051852

Ordered processing of the human immunodeficiency virus type 1 GagPol precursor is influenced by the context of the embedded viral protease.

Steven C Pettit1, Jose C Clemente, Jennifer A Jeung, Ben M Dunn, Andrew H Kaplan.   

Abstract

Ordered and accurate processing of the human immunodeficiency virus type 1 (HIV-1) GagPol polyprotein precursor by a virally encoded protease is an indispensable step in the appropriate assembly of infectious viral particles. The HIV-1 protease (PR) is a 99-amino-acid enzyme that is translated as part of the GagPol precursor. Previously, we have demonstrated that the initial events in precursor processing are accomplished by the PR domain within GagPol in cis, before it is released from the polyprotein. Despite the critical role that ordered processing of the precursor plays in viral replication, the forces that define the order of cleavage remain poorly understood. Using an in vitro assay in which the full-length HIV-1 GagPol is processed by the embedded PR, we examined the effect of PR context (embedded within GagPol versus the mature 99-amino-acid enzyme) on precursor processing. Our data demonstrate that the PR domain within GagPol is constrained in its ability to cleave some of the processing sites in the precursor. Further, we find that this constraint is dependent upon the presence of a proline as the initial amino acid in the embedded PR; substitution of an alanine at this position produces enhanced cleavage at additional sites when the precursor is processed by the embedded, but not the mature, PR. Overall, our data support a model in which the selection of processing sites and the order of precursor processing are defined, at least in part, by the structure of GagPol itself.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16051852      PMCID: PMC1182631          DOI: 10.1128/JVI.79.16.10601-10607.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Gag precursors of HIV and SIV are cleaved into six proteins found in the mature virions.

Authors:  L E Henderson; R C Sowder; T D Copeland; S Oroszlan; R E Benveniste
Journal:  J Med Primatol       Date:  1990       Impact factor: 0.667

2.  Hydrolysis of synthetic chromogenic substrates by HIV-1 and HIV-2 proteinases.

Authors:  L H Phylip; A D Richards; J Kay; J Kovalinka; P Strop; I Blaha; J Velek; V Kostka; A J Ritchie; A V Broadhurst
Journal:  Biochem Biophys Res Commun       Date:  1990-08-31       Impact factor: 3.575

3.  Comparison of three inhibitor complexes of human immunodeficiency virus protease.

Authors:  A L Swain; A Gustchina; A Wlodawer
Journal:  Adv Exp Med Biol       Date:  1991       Impact factor: 2.622

4.  Analysis of retroviral protease cleavage sites reveals two types of cleavage sites and the structural requirements of the P1 amino acid.

Authors:  S C Pettit; J Simsic; D D Loeb; L Everitt; C A Hutchison; R Swanstrom
Journal:  J Biol Chem       Date:  1991-08-05       Impact factor: 5.157

5.  Structural basis of asymmetry in the human immunodeficiency virus type 1 reverse transcriptase heterodimer.

Authors:  J Wang; S J Smerdon; J Jäger; L A Kohlstaedt; P A Rice; J M Friedman; T A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

6.  The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors.

Authors:  R J Mervis; N Ahmad; E P Lillehoj; M G Raum; F H Salazar; H W Chan; S Venkatesan
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

7.  Kinetic characterization and cross-resistance patterns of HIV-1 protease mutants selected under drug pressure.

Authors:  S V Gulnik; L I Suvorov; B Liu; B Yu; B Anderson; H Mitsuya; J W Erickson
Journal:  Biochemistry       Date:  1995-07-25       Impact factor: 3.162

8.  A heptanucleotide sequence mediates ribosomal frameshifting in mammalian cells.

Authors:  H Reil; H Kollmus; U H Weidle; H Hauser
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

9.  Comparison of the HIV-1 and HIV-2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag-Pol polyproteins.

Authors:  J Tözsér; I Bláha; T D Copeland; E M Wondrak; S Oroszlan
Journal:  FEBS Lett       Date:  1991-04-09       Impact factor: 4.124

10.  Substrate analogue inhibition and active site titration of purified recombinant HIV-1 protease.

Authors:  A G Tomasselli; M K Olsen; J O Hui; D J Staples; T K Sawyer; R L Heinrikson; C S Tomich
Journal:  Biochemistry       Date:  1990-01-09       Impact factor: 3.162

View more
  47 in total

1.  Analysis of human immunodeficiency virus matrix domain replacements.

Authors:  Isabel Scholz; Amelia Still; Tenzin Choesang Dhenub; Kelsey Coday; Mike Webb; Eric Barklis
Journal:  Virology       Date:  2007-11-08       Impact factor: 3.616

2.  Uncoupling human immunodeficiency virus type 1 Gag and Pol reading frames: role of the transframe protein p6* in viral replication.

Authors:  Andreas Leiherer; Christine Ludwig; Ralf Wagner
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

3.  Altered gag polyprotein cleavage specificity of feline immunodeficiency virus/human immunodeficiency virus mutant proteases as demonstrated in a cell-based expression system.

Authors:  Ying-Chuan Lin; Ashraf Brik; Aymeric de Parseval; Karen Tam; Bruce E Torbett; Chi-Huey Wong; John H Elder
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

4.  C-Terminal HIV-1 Transframe p6* Tetrapeptide Blocks Enhanced Gag Cleavage Incurred by Leucine Zipper Replacement of a Deleted p6* Domain.

Authors:  Fu-Hsien Yu; Kuo-Jung Huang; Chin-Tien Wang
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

5.  Identification of folding preferences of cleavage junctions of HIV-1 precursor proteins for regulation of cleavability.

Authors:  Hirotaka Ode; Masaru Yokoyama; Tadahito Kanda; Hironori Sato
Journal:  J Mol Model       Date:  2010-05-18       Impact factor: 1.810

6.  The HIV-1 late domain-2 S40A polymorphism in antiretroviral (or ART)-exposed individuals influences protease inhibitor susceptibility.

Authors:  Susan M Watanabe; Viviana Simon; Natasha D Durham; Brittney R Kemp; Satoshi Machihara; Kimdar Sherefa Kemal; Binshan Shi; Brian Foley; Hongru Li; Benjamin K Chen; Barbara Weiser; Harold Burger; Kathryn Anastos; Chaoping Chen; Carol A Carter
Journal:  Retrovirology       Date:  2016-09-06       Impact factor: 4.602

Review 7.  Molecular mechanisms of FIV infection.

Authors:  John H Elder; Magnus Sundstrom; Sohela de Rozieres; Aymeric de Parseval; Chris K Grant; Ying-Chuan Lin
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

8.  Cysteine 95 and other residues influence the regulatory effects of Histidine 69 mutations on Human Immunodeficiency Virus Type 1 protease autoprocessing.

Authors:  Liangqun Huang; Alyssa Hall; Chaoping Chen
Journal:  Retrovirology       Date:  2010-03-23       Impact factor: 4.602

9.  A switch-on mechanism to activate maize ribosome-inactivating protein for targeting HIV-infected cells.

Authors:  Sue Ka-Yee Law; Rui-Rui Wang; Amanda Nga-Sze Mak; Kam-Bo Wong; Yong-Tang Zheng; Pang-Chui Shaw
Journal:  Nucleic Acids Res       Date:  2010-06-17       Impact factor: 16.971

10.  Autoprocessing of human immunodeficiency virus type 1 protease miniprecursor fusions in mammalian cells.

Authors:  Liangqun Huang; Chaoping Chen
Journal:  AIDS Res Ther       Date:  2010-07-28       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.